12 published brand profiles in this category. Cite the individual brand profile for brand-specific facts.
Berg Health - Berg Health is an ai drug discovery company headquartered in Framingham, MA, founded in 2006.
BioSymetrics - BioSymetrics is an ai drug discovery company headquartered in New York, NY, founded in 2015.
Causaly - Both avid readers, the duo envisioned an intelligent technology that could read “at superhuman speed,” extract knowledge including cause-effect evidence, capture the essence of that knowledge, and communicate the learnings with a level of clarity and integrity that would meet the standards of the world’s leading scientists. Meanwhile, the demand for precision medicine was growing and the pace of drug discovery lagged, putting pressure on researchers and pharmaceutical companies to find innovativ
CytoReason - Think of it as the most comprehensive model of human diseases. Modeling and comparing treatments and patient groups so you get a clear map of disease and drug mechanisms.
Deep Genomics - We can do this because of our Biological Foundation (BioFM) Model Platform - a single engine with lab-in-the-loop workflows, AI model development and refinement, fit-for-purpose training datasets, AI output dataset assets, screening technologies, information systems, and software systems. On this common architecture, we build, run and improve the world’s best Biological Foundation Models in an effort to transform the field of drug discovery - finding molecules and targets others would miss, and
FeatureByte - FeatureByte is a ai drug discovery brand headquartered in Singapore, founded in 2021.
Healx - It all started when Dr Tim Guilliams and Dr David Brown met a man named Nick Sireau in 2014.Nick had set up a patient group to help find treatments for an extremely rare genetic disorder that affected his sons. For a decade he worked tirelessly, but the drug discovery process was slow and very expensive - a challenge facing nearly all patient groups today.
Recursion - Dive into Recursion's innovative approach to decoding biology. Join our mission & explore what AI drug discovery companies can do. Contact us today!
Standigm - Standigm is an ai drug discovery company headquartered in Seoul, South Korea, founded in 2015.
twoXAR - twoXAR is an ai drug discovery company headquartered in South San Francisco, CA, founded in 2014.
Verge Genomics - We believe that delivering on the promise of technology requires breaking down the silos between scientists and technologists. Unlike traditional biotechnology companies, our rapidly growing team has experienced-drug-hunters sit side-by-side with leaders in machine learning, statistics, and engineers, creating an environment where disruptive innovation is balanced with disciplined execution.